OC 360 LIVE: Ask The Expert Series

Have questions about Low-Grade Serous Ovarian Cancer (LGSOC)? Now you have the opportunity to get expert answers directly from one of the leading voices in the field!
Join us on July 31 at 10:00 AM CST for a special OC 360 LIVE session with Dr. Rachel Grisham, Section Head of Ovarian Cancer and Director of Gynecologic Medical Oncology at Memorial Sloan Kettering Cancer Center.
Dr. Grisham led the groundbreaking phase 2 trial that resulted in the first FDA-accelerated approval of a drug for LGSOC—and she’s currently heading the global phase 3 confirmatory trial.
Whether you have questions about diagnosis, treatment, remission, recurrence, or survivorship in LGSOC, this is your session to get the answers you need.
📧 Submit your questions by July 29 to: aW5mbyB8IG92YXJjb21lICEgb3Jn
✅ Sign up today and share this invitation with anyone impacted by LGSOC.
Learn. Share. Be Empowered. Only on OC 360 LIVE! 💪

You may also like the following events from Ovarcome:

• Next month, 18th September, 03:00 pm, Ovarcoming Cancer: 13th Annual Global Conference in Houston, Texas